InvestorsHub Logo
Followers 33
Posts 5319
Boards Moderated 0
Alias Born 01/23/2019

Re: None

Wednesday, 10/14/2020 6:10:24 PM

Wednesday, October 14, 2020 6:10:24 PM

Post# of 429111
Marjac, I believe the amicus brief found its way to Hikma's management, compounded by the GSK VS Teva results may have caused their legal ppl to advise them to remove all reference to their patent win along with any mention of GV projection because it proved their intent to infringe and I think it implies that they are guilty of fraud too. Hikma would be tied up in court for yrs. It's not worth their time and money.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News